Siegler James E, Martin-Schild Sheryl
Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Int J Stroke. 2015 Feb;10(2):140-2. doi: 10.1111/ijs.12416.
The National Institutes of Health Stroke Scale was originally designed to stratify patients according to stroke severity for clinical trials, and now it is used to predict disposition and prognosticate functional outcome. Many researchers have also adopted it to trend patient progress over time and detect early neurologic deterioration. However, few investigators have reported its utility in monitoring the daily progress of patients hospitalized for stroke. In the present article, the authors discuss the advantages of daily National Institutes of Health Stroke Scale assessments and our clinical experience with this invaluable tool.
美国国立卫生研究院卒中量表最初是为临床试验中根据卒中严重程度对患者进行分层而设计的,现在则用于预测患者的处置方式和推断功能预后。许多研究人员也采用该量表来追踪患者随时间的病情进展,并检测早期神经功能恶化情况。然而,很少有研究人员报告其在监测因卒中住院患者日常病情进展方面的效用。在本文中,作者讨论了每日进行美国国立卫生研究院卒中量表评估的优势以及我们使用这一宝贵工具的临床经验。